INTRODUCTION AND OBJECTIVES: Continent cutaneous diversion (CCD) is a less commonly utilized diversion choice following open or robotic cystectomy. We have previously described a novel technique for robotic intracorporeal CCD. Meanwhile, continent cutaneous augmentation cystoplasty (CCAC) is a viable option for patients with neurogenic bladder. There is limited worldwide experience performing intracorporeal CCD and no studies describing intracorporeal CCAC. Principles developed in robotic CCD can be readily applied to robotic CCAC. We share our experience with these novel robotic procedures.
INTRODUCTION AND OBJECTIVES: Continent cutaneous diversion (CCD) is a less commonly utilized diversion choice following open or robotic cystectomy. We have previously described a novel technique for robotic intracorporeal CCD. Meanwhile, continent cutaneous augmentation cystoplasty (CCAC) is a viable option for patients with neurogenic bladder. There is limited worldwide experience performing intracorporeal CCD and no studies describing intracorporeal CCAC. Principles developed in robotic CCD can be readily applied to robotic CCAC. We share our experience with these novel robotic procedures.
METHODS: Robotic cystectomy was performed in patients undergoing CCD using a standard 6-port technique. The patient and robot were then repositioned for intracorporeal bowel mobilization and segmentation, ileocolonic anastomosis, uretero-colonic anastomoses, pouch construction, tapering of catheterization channel, reinforcement of ileocecal valve, and stoma creation. All patients were placed on an evidencebased Enhanced Recovery after Surgery protocol postoperatively. Operative times, intraoperative blood loss (EBL), length of stay (LOS), and complications occurring within 90 days of surgery were reviewed.
RESULTS: Ten robotic intracorporeal right colon urinary diversions, including four robotic intracorporeal CCAC and six robotic intracorporeal CCD, were performed. Mean total operative times for cystectomy and intracorporeal urinary diversion were 7.8 and 10 hours for CCAC or CCD respectively (5.4-9.5; 7.9-12.9 ). Mean EBL was 181ml (75-300) for CCAC and 250ml (100-500) for CCD. Mean LOS for CCAC and CCD groups was 10 and 8.8 days respectively (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . A single CCAC patient required transfusion postoperatively. Two high grade complications (Clavien III or greater) were reported in the CCAC group (50%). One high grade complication was reported in the CCD group (17%). Within 30 days of surgery, no CCAC and two CCD patients required readmission (0%, 33%). With a median follow up of 17 months, no incontinence was reported and all patients were able to catheterize without difficulty.
CONCLUSIONS: We demonstrate that robotic intracorporeal CCD and CCAC are technically feasible and safe with good functional outcomes. Further evaluation of these novel surgical techniques along with comparative studies are needed.
Source of Funding: None

PD38-08 DOES THE USE OF RECREATIONAL KETAMINE POSE A CHALLENGE ON BLADDER RECONSTRUCTIVE SURGERY?
Neha Sihra*, Simon Rajendran, Jeremy Ockrim, Dan Wood, London, United Kingdom INTRODUCTION AND OBJECTIVES: Regular use of recreational ketamine causes severe damage to the urinary tract. Patients present with a spectrum of debilitating symptoms including pain, urinary frequency, haematuria and renal failure. The aim of this study was to evaluate management strategies and outcomes in patients undergoing surgical intervention following damage to their urinary tract associated with ketamine use.
METHODS: A retrospective review of prospectively collected data between 2007 and 2015 was performed. Evaluation included CT urogram, cystoscopic evaluation of bladder capacity þ/biopsy. Indications and outcomes for surgical intervention were assessed.
RESULTS: 42 patients were identified. 63% were male and mean age at presentation was 28.7 (range 23-55). All bladder biopsies confirmed an eosinophilic inflammatory infiltrate. A significant proportion of patients (83.3%) were found to have reduced cystoscopic and functional bladder capacity of <300 ml (mean 190 mls, range 70-550). 29 patients were treated conservatively with a view to symptom resolution. 2 patients underwent dilatation for urethral strictures. 4 patients underwent repeated intra-detrusor onabotulinum toxin injection with minimal subjective symptom relief. 2 of these patients proceeded to have major reconstruction.13 patients underwent reconstruction which included simple cystectomy (5/13), substitution cystoplasty (6/13), augmentation cystoplasty (6/13), ileal conduit diversion (1/13), ureteric interposition using ileum (2/13) and appendix Mitrofanoff formation (6/ 13). Of these patients 53.8% (7/13) had one or more complications requiring additional intervention Complications included urine leak (1/7), anastomotic leak (2/7), adhesional small bowel obstruction (1/7), wound necrosis (1/7), ureteric stricture (3/7) and Mitrofanoff stenosis (1/7). One patient was lost to follow up and there was 1 death from pneumonia 5 years following and unrelated to surgery.
CONCLUSIONS: In a tertiary, high volume reconstructive unit we found ketamine patients seemed to be at particular risk of significant peri-operative complications. There did not appear to be any other common factor apart from their use of ketamine and the significant inflammatory change associated with its misuse. We therefore recommend meticulous pre-operative evaluation and multidisciplinary consultation for all patients to determine optimal treatment strategies prior to undertaking major bladder reconstructive surgery. From 2012, patients were prospectively followed with a validated, pictorial pad usage questionnaire. A subgroup of patients received PFPT as an intervention to assist their continence. Interventions focused on improving pelvic floor muscle strength and coordination. Manual, visual and surface EMG biofeedback training were incorporated to improve neuromuscular re-education of the pelvic floor as well as behavioral modifications for bladder re-training, timed voiding and general bladder and bowel health. Frequency of visits started from 1x/ week over 4-6 sessions, and longer thereafter.
Source of
RESULTS: A total of 153 male patients with available pad usage questionnaires were followed from September 2012 to August 2015. Daytime continence rates increase from 59% at <3 months to 92% by 12-18 months postoperatively. Nighttime continence rates increased to 51% by 18-36 months postoperatively. Overall catheterization rate was 13.1%. 17 patients underwent PFPT during this period, with a median age of 70 yrs. There was no significant difference between groups for age, BMI, or Charlson comorbidity index. Univariate analysis showed there is a shorter median time to first daytime continence in PFPT group compared to non-intervention group (89 days vs 182 days respectively; p¼0.06), while this was not significant for the nighttime continence (median 134 vs 311; p¼0.12). Kaplan Meier curves also showed higher continence rates in PFPT group at 1 year (0.710.13) compared to non-PFPT ones (0.60.04), although the difference was not significant (p¼0.25) (figure 1).
CONCLUSIONS: Following ONB, continence improves significantly by 6 months, and plateaus with 92% of patients achieving daytime continence by 12-18 months. Those who received PFPT tend to have faster return to daytime continence in the first year. Further research with bigger sample size is needed to support the value of PFPT in continence after RC and ONB.
Source of Funding: None
PD38-10 FACTORS INFLUENCING INTRAOPERATIVE CONVERSION FROM PLANNED ORTHOTOPIC TO NON-ORTHOTOPIC URINARY DIVERSION DURING RADICAL CYSTECTOMY
Natalie Hartman*, Nariman Ahmadi, Saum Ghodoussipour, Giovanni Caccamani, Daniel Melecchi Freitas, Carlos Fay, Toshitaka Shin, Andre Berger, Mihir Desai, Siamak Daneshmand, Los Angeles, CA INTRODUCTION AND OBJECTIVES: The decision to perform continent orthotopic neobladder (NB) versus non-continent ileal conduit (IC) or continent cutaneous diversion (CCD) at the time of radical cystectomy requires thorough preoperative planning and counseling. Still, preconceived plans may change due to unforeseen intraoperative challenges. Herein, we investigate factors that contribute to this change in plan.
METHODS: Using an IRB approved, prospectively maintained database, we identified 711 patients with bladder cancer who underwent radical cystectomy from 2002 to 2015. Of these, 392 were consented on the day of surgery to NB as their first choice of urinary diversion. 348 patients ultimately received NB while 38 received IC and 6 CCD. We compared those who received NB after being offered such on initial consultation with those who received either IC or CCD to determine factors that may have been involved in the decision.
RESULTS: Factors for intraoperative change in plan are listed in Table 1 . On statistical analysis, patients who ultimately received NB were significantly more likely to have organ confined disease (p¼0.005), lower ASA score (p¼0.006) and to undergo an open surgical approach (p¼0.011) ( Table 2) .
CONCLUSIONS: The factors influencing the choice of urinary diversion in patients undergoing radical cystectomy are complex. Oncologic, metabolic, and technical factors must be weighed along with patient preference on initial consultation. We found that amongst those consented for NB, those with organ confined disease, lower ASA score and those undergoing an open approach, were more likely to ultimately receive a NB. As plans may require change intraoperatively, a more clear understanding of the factors involved will improve shared decision making in the future. Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e743
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